title: French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testing.
abstract: To assess the impact of BRCA1/2 genetic test results on cancer-free women's breast-self-examination (BSE) practices and to prospectively determine their influence on psychological functioning. A prospective longitudinal study on French women's BSE practices and frequencies in BRCA1/2 carriers (N = 217) and non-carriers (N = 313) 1 and 2 years following disclosure of the test results, along with psychological factors predicting BSE practices. Before disclosure, BSE was practised by 47.2% of the women, and increased to 57.3% 1 year later. No change in the women's practices was noted between 12 and 24 months after the test. Carriers and non-carriers practicing regularly BSE at baseline were, respectively 8 to 6 times more likely to be practising BSE regularly at 12 months after being tested. Among the carriers, having fewer depressive symptoms at baseline and believing in the ability of BSE to detect breast cancer were found to be the most decisive factors associated with BSE practices 1 year after disclosure, following adjustment for BSE baseline practices. Among the non-carriers, believing in the ability of BSE to detect breast cancer, greater post-test anxiety, and a higher perceived risk of breast cancer were found to be predictors of post-test BSE practices after adjusting for BSE baseline practices. In France, where performing BSE is neither mandatory nor recommended, an increase in BSE practices was found to occur after disclosure of women's genetic test results, regardless of their carrier status.
authors.affiliation: INSERM, UMR912, Marseille, France.
authors.forename: C
authors.initials: C
authors.lastname: Maheu
authors.forename: T
authors.initials: T
authors.lastname: Apostolidis
authors.forename: A
authors.initials: A
authors.lastname: Petri-Cal
authors.forename: E
authors.initials: E
authors.lastname: Mouret-Fourme
authors.forename: M
authors.initials: M
authors.lastname: Gauthier-Villars
authors.forename: C
authors.initials: C
authors.lastname: Lasset
authors.forename: P
authors.initials: P
authors.lastname: Berthet
authors.forename: J-P
authors.initials: JP
authors.lastname: Fricker
authors.forename: O
authors.initials: O
authors.lastname: Caron
authors.forename: E
authors.initials: E
authors.lastname: Luporsi
authors.forename: L
authors.initials: L
authors.lastname: Gladieff
authors.forename: C
authors.initials: C
authors.lastname: Noguès
authors.forename: C
authors.initials: C
authors.lastname: Julian-Reynier
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D019313:BRCA1 Protein / Q000235:genetics*; D024682:BRCA2 Protein / Q000235:genetics*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000523:psychology; D016504:Breast Self-Examination / Q000523:psychology*; D005260:Female; D005602:France; D005820:Genetic Testing; D006579:Heterozygote; D006801:Humans; D008137:Longitudinal Studies; D008875:Middle Aged; D011446:Prospective Studies; D012959:Socioeconomic Factors; D013997:Time Factors; D055815:Young Adult
chemical_list: D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D024682:BRCA2 Protein; C551750:BRCA2 protein, human